Regulatory issues: an academic viewpoint from Asia (ex-Japan).
Regulatory reforms, together with large patient pools and increasing numbers of well-trained clinicians, have facilitated the development of clinical trials in Asia. Current regulatory and ethical issues are discussed.
Chen
Christopher P L-H
CP
Department of Neurology, Singapore General Hospital, Singapore. gnrcc@sgh.com.sg
D000368:Aged; D001208:Asia; D002986:Clinical Trials as Topic / Q000941:ethics / Q000331:legislation & jurisprudence; D015140:Dementia, Vascular / Q000628:therapy; D026690:Ethics, Clinical; D033161:Government Regulation; D017408:Guidelines as Topic; D006801:Humans; D007400:Interprofessional Relations